CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes.
The cystic fibrosis transmembrane conductance regulator (CFTR) plays a crucial role in regulating fluid secretion by the airways, intestines, sweat glands and other epithelial tissues. It is well established that the CFTR is a cAMP-activated, nucleotide-dependent anion channel, but additional functions are often attributed to it, including regulation of the epithelial sodium channel (ENaC). The absence of CFTR-dependent ENaC inhibition and the resulting sodium hyperabsorption were postulated to be a major electrolyte transport abnormality in cystic fibrosis (CF)-affected epithelia. Several ex vivo studies, including those that used the Xenopus oocyte expression system, have reported ENaC inhibition by activated CFTR, but contradictory results have also been obtained. Because CFTR-ENaC interactions have important implications in the pathogenesis of CF, the present investigation was undertaken by our three independent laboratories to resolve whether CFTR regulates ENaC in oocytes and to clarify potential sources of previously reported dissimilar observations. Using different experimental protocols and a wide range of channel expression levels, we found no evidence that activated CFTR regulates ENaC when oocyte membrane potential was carefully clamped. We determined that an apparent CFTR-dependent ENaC inhibition could be observed when resistance in series with the oocyte membrane was not low enough or the feedback voltage gain was not high enough. We suggest that the inhibitory effect of CFTR on ENaC reported in some earlier oocyte studies could be attributed to problems arising from high levels of channel expression and suboptimal recording conditions, that is, large series resistance and/or insufficient feedback voltage gain.
Nagel
G
G
Max-Planck-Institute of Biophysics, Frankfurt am Main, Germany. georg.nagel@botanik.uni-wuerzburg.de
Barbry
P
P
Chabot
H
H
Brochiero
E
E
Hartung
K
K
Grygorczyk
R
R
D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000378:metabolism*; D053503:Epithelial Sodium Channels; D006801:Humans; D015640:Ion Channel Gating / Q000502:physiology*; D008564:Membrane Potentials / Q000502:physiology; D009865:Oocytes / Q000378:metabolism*; D018408:Patch-Clamp Techniques / Q000379:methods*; D011994:Recombinant Proteins / Q000378:metabolism; D015222:Sodium Channels / Q000378:metabolism*; D014982:Xenopus laevis
C505032:CFTR protein, human; D053503:Epithelial Sodium Channels; D011994:Recombinant Proteins; D015222:Sodium Channels; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D000242:Cyclic AMP
Cell. 1995 Jun 30;81(7):1063-73
7541313
Science. 1995 Aug 11;269(5225):847-50
7543698
Science. 1996 Mar 29;271(5257):1876-9
8596959
Pflugers Arch. 1997 Dec;435(1):178-81
9359918
Am J Physiol. 1997 Nov;273(5 Pt 2):F843-8
9374850
J Physiol. 1998 May 1;508 ( Pt 3):825-36
9518736
J Clin Invest. 1998 Jul 1;102(1):15-21
9649552
Physiol Rev. 1999 Jan;79(1 Suppl):S3-S22
9922374
Physiol Rev. 1999 Jan;79(1 Suppl):S23-45
9922375
Physiol Rev. 1999 Jan;79(1 Suppl):S47-75
9922376
Physiol Rev. 1999 Jan;79(1 Suppl):S77-S107
9922377
Physiol Rev. 1999 Jan;79(1 Suppl):S145-66
9922379
Physiol Rev. 1999 Jan;79(1 Suppl):S175-91
9922381
Physiol Rev. 1999 Jan;79(1 Suppl):S215-55
9922383
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5310-5
10220462
J Membr Biol. 1999 Jun 1;169(3):175-88
10354464
J Gen Physiol. 1999 Jul;114(1):55-70
10398692
Biophys J. 1999 Oct;77(4):1980-91
10512818
J Physiol. 1952 Apr;116(4):424-48
14946712
Biophys J. 1960 Nov;1:161-202
13775643
J Physiol. 1949 Mar 1;108(1):37-77
18128147
FEBS Lett. 1996 Feb 26;381(1-2):47-52
8641437
Ion Channels. 1996;4:115-67
8744208
Am J Physiol. 1997 Feb;272(2 Pt 1):C657-66
9124310
Nature. 1999 Nov 18;402(6759):301-4
10580502
Biochim Biophys Acta. 1999 Dec 6;1461(2):263-74
10581360
J Biol Chem. 2000 Feb 11;275(6):3729-32
10660517
Pflugers Arch. 2000 Mar;439(5):610-7
10764221
J Biol Chem. 2000 May 5;275(18):13266-74
10788432
J Biol Chem. 2000 Sep 8;275(36):27947-56
10821834
EMBO Rep. 2001 Mar;2(3):249-54
11266369
EMBO Rep. 2001 Nov;2(11):1047-51
11606421
J Gen Physiol. 2002 Feb;119(2):199-207
11815669
J Biol Chem. 2002 Mar 15;277(11):8928-33
11773060
J Gen Physiol. 2002 Sep;120(3):407-18
12198094
EMBO J. 2002 Nov 1;21(21):5662-72
12411484
J Biol Chem. 2002 Dec 27;277(52):50341-7
12386156
J Biol Chem. 2002 Dec 27;277(52):50503-9
12403779
Pflugers Arch. 2003 Jan;445(4):499-503
12548396
Pflugers Arch. 2003 Jan;445(4):504-12
12548397
Pflugers Arch. 2003 Jan;445(4):513-21
12548398
Pflugers Arch. 2003 Jan;445(4):522-8
12548399
J Membr Biol. 2003 Mar 15;192(2):101-10
12682798
Curr Opin Pulm Med. 2003 Nov;9(6):486-91
14534400
J Biol Chem. 2004 May 28;279(22):23183-92
15047694
J Biol Chem. 2004 Jun 4;279(23):23900-7
15069064
J Biol Chem. 1997 May 30;272(22):14037-40
9162024
Pflugers Arch. 1997 Aug;434(4):484-91
9211816
J Cyst Fibros. 2004 Aug;3 Suppl 2:109-11
15463940
J Membr Biol. 1975 Apr 23;21(1-2):25-47
1195338
N Engl J Med. 1981 Dec 17;305(25):1489-95
7300874
Science. 1983 Sep 9;221(4615):1067-70
6308769
Biophys J. 1984 Oct;46(4):507-14
6498268
J Clin Invest. 1986 Nov;78(5):1245-52
3771796
Pflugers Arch. 1986;407 Suppl 2:S123-7
3822760
Science. 1989 Sep 8;245(4922):1066-73
2475911
Nature. 1991 Jul 4;352(6330):70-3
1712081
Cell. 1991 Nov 15;67(4):775-84
1718606
Science. 1992 Apr 24;256(5056):530-2
1373908
Methods Enzymol. 1992;207:100-22
1528114
Nature. 1992 Nov 5;360(6399):81-4
1279437
Nature. 1993 Feb 4;361(6411):467-70
8381523
FEBS Lett. 1993 Feb 22;318(1):95-9
8382172
Annu Rev Physiol. 1993;55:609-30
7682047
Am J Physiol. 1994 May;266(5 Pt 1):C1478-83
7515571
J Biol Chem. 1994 Aug 12;269(32):20584-91
7519611
Annu Rev Physiol. 1995;57:387-416
7539989